Clinical Diagnostics

As a pioneer in the clinical validation of new technologies, and as a result of its wide expertise in nucleic acid analysis, DNAVision has developed a strong position in partnering with biotech and diagnostic companies, supporting them in their discovery and validation of genetic and genomic signatures and promoting these signatures as diagnostic assays in our central laboratory. The recent advances in genome and exome sequencing has opened a new paradigm and our efforts are currently focused on the clinical development of these technologies.

DNAVision has built up its reputation as an expert, not only mastering a broad range of technologies and related downstream data analysis, but also by processing customer samples in a high quality environment: ISO17025 accreditation for genotyping, sequencing (BELAC Certificate 293-Test) CLIA accreditation and CAP certification ...

DNAVision is currently combining these two key assets (technological know-how and translational validation within QA system) together to bring exome/genome sequencing to the clinical fields in close collaboration with our private and public partners.

DNAVision's expertise is focused on:
- Specimen logistics, acting as a European Central Laboratory.
- Consulting for implementation of genome sequencing into clinical settings
- Assay design and qualification - Clinical validation of assays
- GLP or CLIA lab for testing in clinical trials or for routine diagnostic processing

information ?
Contact us